role alpha num num galactosyl epitope natural anti-gal antibody oncogenesis pubmed ncbi abstract glycoconjugates antibodies vital components host-tumor interaction review concentrates oncological implications research alpha gal triad alpha num num galactosyl epitope alpha gal enzyme responsible construction alpha num galactosyl transferase alpha num gt antibody anti-gal alpha gal epitopes previously assumed absent human tissue demonstrated human cancer cell lines senescent red blood cells graves disease thyrocytes alpha-gal presence neoplastic lines correlated increased metastatic formation animal models mechanisms human response neoantigens complex natural anti-gal antibodies exist high titers normal sera predicting immunological recognition cells expressing alpha gal epitopes hypotheses vary pathogenic contributions metastasis-associated phenomena de novo expression alpha gal unmasking desialylation means alpha gal sporadically expressed human tissue remain unknown galactosyl transferase produces epitope constitutively expressive animals undergone significant mutation genomic level humans pathological re-expression presumed require permissive cellular level detailing alterations prerequisite comprehension metastatic phenotype context possibility therapeutic strategies affecting alpha gal expression discussed 
